Stock Analysis on Net

Eli Lilly & Co. (NYSE:LLY)

Income Statement

Eli Lilly & Co., consolidated income statement

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Revenue 45,042,700 34,124,100 28,541,400 28,318,400 24,539,800
Cost of sales (8,418,300) (7,082,200) (6,629,800) (7,312,800) (5,483,300)
Gross margin 36,624,400 27,041,900 21,911,600 21,005,600 19,056,500
Research and development (10,990,600) (9,313,400) (7,190,800) (6,930,700) (5,976,300)
Marketing, selling, and administrative (8,593,800) (7,403,100) (6,440,400) (6,431,600) (6,121,200)
Acquired in-process research and development (3,280,400) (3,799,800) (908,500) (970,100) (769,800)
Asset impairment, restructuring, and other special charges (860,600) (67,700) (244,600) (316,100) (131,200)
Operating income 12,899,000 6,457,900 7,127,300 6,357,100 6,058,000
Interest expense (780,600) (485,900) (331,600) (339,800) (359,600)
Interest income 175,200 173,600 62,800 25,400 33,000
Net investment gains (losses) on equity securities (49,500) (20,200) (410,700) 176,900 1,442,200
Debt extinguishment loss (405,200)
Retirement benefit plans 461,700 461,900 372,900 289,700 251,800
Other income (expense) (25,400) (32,700) (14,300) 51,400 (195,500)
Other, net, income (expense) (218,600) 96,700 (320,900) (201,600) 1,171,900
Income before income taxes 12,680,400 6,554,600 6,806,400 6,155,500 7,229,900
Income taxes (2,090,400) (1,314,200) (561,600) (573,800) (1,036,200)
Net income 10,590,000 5,240,400 6,244,800 5,581,700 6,193,700

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Income statement item Description The company
Revenue Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Eli Lilly & Co. revenue increased from 2022 to 2023 and from 2023 to 2024.
Operating income The net result for the period of deducting operating expenses from operating revenues. Eli Lilly & Co. operating income decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Eli Lilly & Co. income before income taxes decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Eli Lilly & Co. net income decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.